We previously showed that the duodenal hyperemic response to acid occurs th
rough activation of capsaicin-sensitive afferent nerves with subsequent rel
ease of vasodilatory substances such as calcitonin gene-related peptide (CG
RP) and nitric oxide. We then tested the hypothesis that similar factors re
gulate duodenal mucus gel thickness. Gel thickness was optically measured u
sing in vivo microscopy in anesthetized rats. Duodenal mucosae were superfu
sed with pH 7.0 buffer with vanilloid receptor agonist capsaicin, bradykini
n, or PGE(2) injection or were challenged with pH 2.2 solution, with or wit
hout the vanilloid antagonist capsazepine, human CGRP-(8-37), N-G-nitro-L-a
rginine methyl ester, and indomethacin. Other rats underwent sensory ablati
on with high-dose capsaicin pretreatment. Acid, bradykinin, capsaicin, and
PGE(2) all quickly thickened the gel. Antagonism of vanilloid and CGRP rece
ptors, inhibition of nitric oxide synthase, and sensory deafferentation del
ayed gel thickening, suggesting that the capsaicin pathway mediated the ini
tial burst of mucus secretion that thickened the gel. Indomethacin abolishe
d gel thickening due to acid, bradykinin, and capsaicin. Inhibition of gel
thickening by indomethacin in response to multiple agonists suggests that c
yclooxygenase activity is essential for duodenal gel thickness regulation.
Duodenal afferent neural pathways play an important role in the modulation
of cyclooxygenase-mediated physiological control of gel thickness.